Researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) have found that a certain subpopulation of cells that enters a patient’s skin and blood during immunotherapy is behind the excellent and long-lasting immune responses to cancer that some survivors develop.
Dartmouth researchers convert a standard linear accelerator used for delivery of radiation therapy cancer treatment, to deliver an ultra-high-dose rate radiation therapy beam to patients “in a flash.”
Lionel D. Lewis, MD, MA, MB BCh, has been elected as a fellow of the British Pharmacological Society, a premier global society in the science of pharmacology.
Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer which will allow for innovations to the marketplace for the benefit of cancer patients, and provide Dartmouth students with learning opportunities in biomedical entrepreneurship.
A newly awarded $820,000 grant from The National Cancer Institute will allow a team of multi-disciplinary investigators to increase clinical trial awareness and participation for rural patients who make up almost half of the area served by Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center.
A new study uncovers how the most commonly mutated tumor suppressor gene in cancer and the most commonly mutated oncogene in cancer cooperate to drive formation of pancreatic cancer.
A $328,000 National Cancer Institute (NCI) grant will enable researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) to investigate one of the mechanisms that may be responsible for the body’s inability to fight COVID-19.
More than 2,500 participants came together virtually between June 1 and July 11 to raise $2,800,000 for Norris Cotton Cancer Center during the Prouty, featuring a variety of activities and participants from around the globe.
A research team at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center has found that the same vaccination programs that target human papillomavirus (hrHPV) strains in the United States may not be as effective in protecting other populations of women from the disease.
$15.5 million NCI grant continues support for northern New England’s only comprehensive center.
Upcoming Events
This page may link to PDF files. Use this link to download Adobe Reader if needed.